These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 17655562
1. Predictors of course in obsessive-compulsive disorder: logistic regression versus Cox regression for recurrent events. Kempe PT, van Oppen P, de Haan E, Twisk JW, Sluis A, Smit JH, van Dyck R, van Balkom AJ. Acta Psychiatr Scand; 2007 Sep; 116(3):201-10. PubMed ID: 17655562 [Abstract] [Full Text] [Related]
2. Predicting therapy outcome in patients with early and late obsessive-compulsive disorder (EOCD and LOCD). Langner J, Laws M, Röper G, Zaudig M, Hauke W, Piesbergen C. Behav Cogn Psychother; 2009 Oct; 37(5):485-96. PubMed ID: 19796435 [Abstract] [Full Text] [Related]
3. Behavioural group therapy for obsessive-compulsive disorder in Norway. An open community-based trial. Håland AT, Vogel PA, Lie B, Launes G, Pripp AH, Himle JA. Behav Res Ther; 2010 Jun; 48(6):547-54. PubMed ID: 20359692 [Abstract] [Full Text] [Related]
4. Cognitive versus behavior therapy: processes of change in the treatment of obsessive-compulsive disorder. Anholt GE, Kempe P, de Haan E, van Oppen P, Cath DC, Smit JH, van Balkom AJ. Psychother Psychosom; 2008 Jun; 77(1):38-42. PubMed ID: 18087206 [Abstract] [Full Text] [Related]
7. Duration of untreated illness as a predictor of treatment response and remission in obsessive-compulsive disorder. Dell'Osso B, Buoli M, Hollander E, Altamura AC. World J Biol Psychiatry; 2010 Feb; 11(1):59-65. PubMed ID: 20001657 [Abstract] [Full Text] [Related]
8. Differences between early and late drop-outs from treatment for obsessive-compulsive disorder. Aderka IM, Anholt GE, van Balkom AJ, Smit JH, Hermesh H, Hofmann SG, van Oppen P. J Anxiety Disord; 2011 Oct; 25(7):918-23. PubMed ID: 21664103 [Abstract] [Full Text] [Related]
12. Long-term course and outcome of obsessive-compulsive patients after cognitive-behavioral therapy in combination with either fluvoxamine or placebo: a 7-year follow-up of a randomized double-blind trial. Rufer M, Hand I, Alsleben H, Braatz A, Ortmann J, Katenkamp B, Fricke S, Peter H. Eur Arch Psychiatry Clin Neurosci; 2005 Apr; 255(2):121-8. PubMed ID: 15812606 [Abstract] [Full Text] [Related]
13. A prospective long-term follow-up study of alexithymia in obsessive-compulsive disorder. Rufer M, Ziegler A, Alsleben H, Fricke S, Ortmann J, Brückner E, Hand I, Peter H. Compr Psychiatry; 2006 Apr; 47(5):394-8. PubMed ID: 16905403 [Abstract] [Full Text] [Related]
14. Metacognitive therapy for obsessive-compulsive disorder: a case series. Fisher PL, Wells A. J Behav Ther Exp Psychiatry; 2008 Jun; 39(2):117-32. PubMed ID: 17418090 [Abstract] [Full Text] [Related]